Physician
Obstetrics & Gynecology
Dr. Lois M. Ramondetta, MD
|
|
Give Review
Lois Ramondetta is an expert in the field of Obstetrics & Gynecology. She graduated from Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74/67 in Research/PrimaryCare. She received awards:"Top Doctors:SE Texas", "Fellow (FACS)" and "Fellow (FACOG)". Lois Ramondetta is also published. She has 89 publications published. The lastest publication: "Endometrial cancer in polyps associated with tamoxifen use.' Lois Ramondetta accepts all Medicare patients.
Publications
- Dying well: How equal is end of life care among gynecologic oncology patients?
- Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with Cervical cancer.
- Bevacizumab for advanced Cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
- Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian Cancer cells.
- Targeting those with decreased meaning and peace: a supportive care opportunity.
- Factors Associated With Grade 3 or 4 Treatment-Related Toxicity in Women With Advanced or Recurrent Cervical Cancer: An Exploratory Analysis of NRG Oncology/Gynecologi...
- Does Death Anxiety Affect End-of-Life Care Discussions?
- Pemetrexed and Cisplatin for the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix: A Limited Access Phase II Trial of the Gynecologic Oncology G...
- Missed opportunities: Patterns of medical care and hospice utilization among ovarian Cancer patients.
- Overall survival after Pelvic exenteration for gynecologic malignancy.
- Patient Preferences for Side Effects Associated With Cervical Cancer Treatment.
- Improved survival with bevacizumab in advanced Cervical cancer.
- Surprising results regarding MASCC members' beliefs about spiritual care.
- Use of Social Media to Conduct a Cross-Sectional Epidemiologic and Quality of Life Survey of Patients with Neuroendocrine Carcinoma of the Cervix: A Feasibility Study.
- β-blockers: a new role in Cancer chemotherapy?
- Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian Cancer.
- Risk of residual disease and invasive Carcinoma in women treated for adenoCarcinoma in situ of the cervix.
- A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous Carcinoma of the endometrium.
- Importance of adrenergic pathways in women's Cancers.
- Anatomic Location of PET-Positive Aortocaval Nodes in Patients with Locally Advanced Cervical Cancer: Implications for Surgical Staging.
- Work related stress among gynecologic oncologists.
- Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced Cervical cancer1: a prospective correlation of surgical findings with positron emission to...
- Prospective evaluation of insulin resistance among endometrial Cancer patients.
- A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent Uterine carcinosarcoma.
- Caregiver symptom burden: the risk of caring for an underserved patient with advanced Cancer.
- Rate of para-aortic lymph node micrometastasis in patients with locally advanced Cervical cancer.
- A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial Carcinoma.
- Combination of gemcitabine and cisplatin is highly active in women with endometrial Carcinoma: results of a prospective phase 2 trial.
- Lymphadenectomy during endometrial Cancer staging: practice patterns among gynecologic oncologists.
- Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical Carcinoma: a Gynecologic Oncology Group study.
- Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital Status matter?
- Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenoCarcinoma or low-grade endometrial stromal sarcoma.
- Social factors affecting treatment of Cervical cancer: ethical issues and policy implications.
- Comparison of treatment tolerance and outcomes in patients with Cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with sta...
- Eleven years: the long and winding road.
- From technician to professional: integrating spirituality into medical practice.
- Determination of the mechanism of gemcitabine modulation of cisplatin drug resistance in panel of human endometrial Cancer cell lines.
- Advanced Cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy.
- Active coping mediates the association between religion/spirituality and quality of life in ovarian Cancer.
- Active coping mediates the association between religion/spirituality and functional well-being in ovarian Cancer.
- Adult granulosa cell tumors of the ovary in two first-degree relatives.
- Practice patterns of SGO members for stage IIIA endometrial Cancer.
- Imatinib mesylate (gleevec)--targeted kinases are expressed in Uterine sarcomas.
- Phase II trial of capecitabine in recurrent squamous cell Carcinoma of the cervix.
- The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal Ovarian tumors.
- Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial Cancer, endometrial hyperplasia, and normal endometrium.
- Expression of imatinib mesylate-targeted kinases in endometrial Carcinoma.
- Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
- An in vitro study of the inhibitory activity of gemcitabine and platinum agents in human endometrial Carcinoma cell lines.
- Uterine papillary serous Carcinoma (UPSC): a single institution review of 129 cases.
- Spirituality and religion in the "art of dying".
- Use of a vacuum-assisted closure device in the treatment of recurrent Paget's disease of the vulva.
- A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent Uterine malignant mixed müllerian tumors with evaluation of potential molec...
- Mentorship and productivity among gynecologic oncology fellows.
- Ethics consultation on a gynecologic oncology service: an opportunity for physician education.
- In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial Cancer cell lines.
- Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics.
- In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected antiCancer agents in a panel of human endometrial Cancer cell lines.
- In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected antiCancer agents in a panel of human ovarian Cancer cell lines.
- PTEN expression in tamoxifen-associated endometrial Cancers.
- Development of endometrial cancer after radiation treatment for cervical Carcinoma.
- Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial Carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death:...
- Radiation-associated endometrial Cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial Cancers.
- Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endoCervical lesions.
- Treatment of uterine papillary serous Carcinoma with paclitaxel.
- A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian Cancer.
- Physical activity and obesity in endometrial Cancer survivors: associations with pain, fatigue, and physical functioning.
- Ethnic disparities in Cervical cancer survival among Medicare eligible women in a multiethnic population.
- Node-positive adenoCarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
- "Doctor, what did I do to deserve this?".
- Exploring the role of religiosity and spirituality in amniocentesis decision-making among Latinas.
- Religious and spiritual beliefs of gynecologic oncologists may influence medical decision making.
- Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial Carcinoma.
- Surgical removal of a gigantic abdominal mass: a multidisciplinary approach.
- The presence of human papillomavirus or p16 in six cases of retroperitoneal Carcinoma.
- Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent Cervical cancer: a Gyn...
- Percutaneous abscess drainage in gynecologic Cancer patients.
- Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study.
- Metastatic uterine papillary serous Carcinoma to the pericardium.
- Expression of cell-cycle mediators in ovarian Cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
- Mixed choriocarcinoma in a PostMenopausal patient.
- Atypical Meigs' syndrome and bilateral Ovarian stromal hyperplasia. A case report.
- A comparative analysis of Ki-67, p53, and p21WAF1CIP1 expression in tamoxifen associated endometrial Carcinomas.
- Endometrial Cancer in polyps associated with tamoxifen use.
- Spirituality in gynecological oncology: a review.
- Clinical challenges presented by three simultaneous solid tumors.
- Survey of Female gynecologic oncologists and fellows: balancing professional and personal life.
- Heterogeneity of stage IIIA endometrial Carcinomas: implications for adjuvant therapy.
Schools
UmdnjRobt W Johnson Med Sch
Thos Jefferson University Hospital
Procedures Preformed
- Colposcopy
- Destruction or Excision of Vaginal Lesions
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Gynecologic Cancer Screening
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Top Doctors:SE Texas
- Fellow (FACS)
- Fellow (FACOG)
Education
-
Thomas Jefferson University -
Rutgers Robert Wood Johnson Medical School
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1801987508 | |
| NPPES Provider LastName | RAMONDETTA | |
| NPPES Provider FirstName | LOIS | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 163.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 37.0 | |
| Percent Opioid Claims | 22.7 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801987508 |
| Last Name Of The Provider | RAMONDETTA |
| First Name Of The Provider | LOIS |
| View All |
Similar Doctors
|
Dr. Richard D. Drake, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Hilaire W. Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph A. Lucci III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Gershenson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Irene E. Aga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas W. Burke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bani M. Ratan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alexander Reiter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles F. Levenback, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne B. Alaniz, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alpa M. Nick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Padraic Chisholm, MD
This Doctor is OpenDoctor Recommended.
|